Eversept Partners, LP

Position in XENE — Xenon Pharmaceuticals Inc.

CIK 1697013 NEW YORK, NY

Position in XENE

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$11,862,671

+$4,327,943 QoQ

Shares Held

196,532

+51.7% QoQ

Ownership

0.203%

of shares outstanding

% of Portfolio

0.65%

of 13F equity value

Holder Rank

#82

of 314 holders

Holding Since

Mar 2020

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Eversept Partners, LP holds $859,319,346 across 72 Biotechnology names. XENE ranks #17 (1.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABVX	Abivax S.A.	913,880	$121,783,648
2	VERA	Vera Therapeutics, Inc.	2,212,770	$94,949,960
3	CLDX	Celldex Therapeutics, Inc.	1,785,941	$66,454,864
4	SNDX	Syndax Pharmaceuticals Inc	2,798,210	$61,168,870
5	IONS	Ionis Pharmaceuticals Inc	664,684	$52,702,794
6	TVTX	Travere Therapeutics, Inc.	798,973	$45,389,656
7	PCVX	Vaxcyte, Inc.	629,952	$36,619,109
8	GERN	Geron Corp	18,717,422	$23,958,300

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$11,862,671	196,532	+51.7%	Shares	Sole	2026-08-14
2026-03-31	$7,534,728	129,574	-44.0%	Shares	Sole	2026-05-15
2025-12-31	$10,370,451	231,380	+48.8%	Shares	Sole	2026-02-17
2024-12-31	$6,097,168	155,540	-9.2%	Shares	Sole	2025-02-14
2023-06-30	$6,598,053	171,378	-15.7%	Shares	Sole	2023-11-08
2023-03-31	$7,275,104	203,272	-26.3%	Shares	Sole	2023-11-08
2022-12-31	$10,871,008	275,704	+6.2%	Shares	Sole	2023-11-08
2022-09-30	$9,371,993	259,612	-44.3%	Shares	Sole	2023-11-08
2022-06-30	$14,173,012	465,911	+13.6%	Shares	Sole	2023-11-08
2022-03-31	$12,534,341	410,021	+95.7%	Shares	Sole	2023-11-08
2021-12-31	$6,545,373	209,519	+192.7%	Shares	Sole	2023-11-08
2020-03-31	$811,841	71,591	—	Shares	Sole	2023-11-08
No filing history on record for this holder in this stock.